相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Kynurenine pathway in kidney diseases
Izabela Zakrocka et al.
PHARMACOLOGICAL REPORTS (2022)
Plasma markers in pulmonary hypertension subgroups correlate with patient survival
T. Koudstaal et al.
RESPIRATORY RESEARCH (2021)
Cellular sources of interleukin-6 and associations with clinical phenotypes and outcomes in pulmonary arterial hypertension
Catherine E. Simpson et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Plasma kynurenines and prognosis in patients with heart failure
Anders Lund et al.
PLOS ONE (2020)
l-Tryptophan-Induced Vasodilation Is Enhanced in Preeclampsia Studies on Its Uptake and Metabolism in the Human Placenta
Michelle Broekhuizen et al.
HYPERTENSION (2020)
DNA damage-induced PARP1 activation confers cardiomyocyte dysfunction through NAD+ depletion in experimental atrial fibrillation
Deli Zhang et al.
NATURE COMMUNICATIONS (2019)
Dysregulation of the Tryptophan Pathway Evidences Gender Differences in COPD
Shama Naz et al.
METABOLITES (2019)
Selective BMP-9 Inhibition Partially Protects Against Experimental Pulmonary Hypertension
Ly Tu et al.
CIRCULATION RESEARCH (2019)
Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives
Marc Humbert et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Haemodynamic definitions and updated clinical classification of pulmonary hypertension
Gerald Simonneau et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Macrophage de novo NAD(+) synthesis specifies immune function in aging and inflammation
Paras S. Minhas et al.
NATURE IMMUNOLOGY (2019)
The prognostic value of various biomarkers in adults with pulmonary hypertension; a multi-biomarker approach
Laurie W. Geenen et al.
AMERICAN HEART JOURNAL (2019)
NAD metabolism: Implications in aging and longevity
Keisuke Yaku et al.
AGEING RESEARCH REVIEWS (2018)
Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence
Luis Rajman et al.
CELL METABOLISM (2018)
NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR
Jun Yoshino et al.
CELL METABOLISM (2018)
Raising NAD in Heart Failure Time to Translate?
Matthew A. Walker et al.
CIRCULATION (2018)
Ectopic upregulation of membrane-bound IL6R drives vascular remodeling in pulmonary arterial hypertension
Yuichi Tamura et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Impact of declining renal function on outcomes in pulmonary arterial hypertension: A REVEAL registry analysis
Murali M. Chakinala et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2018)
De novo NAD+ biosynthetic impairment in acute kidney injury in humans
Ali Poyan Mehr et al.
NATURE MEDICINE (2018)
Inflammation-Related Mechanisms in Chronic Kidney Disease Prediction, Progression, and Outcome
Simona E. Mihai et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
De novo NAD+ synthesis enhances mitochondrial function and improves health
Elena Katsyuba et al.
NATURE (2018)
Role of NAD+ and mitochondrial sirtuins in cardiac and renal diseases
Kathleen A. Hershberger et al.
NATURE REVIEWS NEPHROLOGY (2017)
Kynurenines: Tryptophan's metabolites in exercise, inflammation, and mental health
Igor Cervenka et al.
SCIENCE (2017)
Metabolic dysfunction in pulmonary hypertension: from basic science to clinical practice
Stephen Y. Chan et al.
EUROPEAN RESPIRATORY REVIEW (2017)
Clinical trial protocol for TRANSFORM-UK: A therapeutic open-label study of tocilizumab in the treatment of pulmonary arterial hypertension
Jules Hernandez-Sanchez et al.
PULMONARY CIRCULATION (2017)
Importance of kynurenine in pulmonary hypertension
Bence M. Nagy et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2017)
Nicotinamide Phosphoribosyltransferase Promotes Pulmonary Vascular Remodeling and Is a Therapeutic Target in Pulmonary Arterial Hypertension
Jiwang Chen et al.
CIRCULATION (2017)
Impact of Plasma Kynurenine Level on Functional Capacity and Outcome in Heart Failure. - Results From Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF)
Masaaki Konishi et al.
CIRCULATION JOURNAL (2017)
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)
Nazzareno Galie et al.
EUROPEAN HEART JOURNAL (2016)
Normal myocardial strain values using 2D speckle tracking echocardiography in healthy adults aged 20 to 72years
Myrthe E. Menting et al.
ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES (2016)
Activity of the kynurenine pathway and its interplay with immunity in patients with pulmonary arterial hypertension
Malgorzata Jasiewicz et al.
HEART (2016)
Metabolic Profiling of Right Ventricular-Pulmonary Vascular Function Reveals Circulating Biomarkers of Pulmonary Hypertension
Gregory D. Lewis et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Kynurenine causes vasodilation and hypotension induced by activation of KCNQ-encoded voltage-dependent K+ channels
Kensuke Sakakibara et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2015)
NAD+ in aging, metabolism, and neurodegeneration
Eric Verdin
SCIENCE (2015)
The Metabolic Basis of Pulmonary Arterial Hypertension
Gopinath Sutendra et al.
CELL METABOLISM (2014)
Definitions and Diagnosis of Pulmonary Hypertension
Marius M. Hoeper et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
The NAD+ Precursor Nicotinamide Riboside Enhances Oxidative Metabolism and Protects against High-Fat Diet-Induced Obesity
Caries Canto et al.
CELL METABOLISM (2012)
The efficacy of tocilizumab in a patient with pulmonary arterial hypertension associated with Castleman's disease
Yoh Arita et al.
HEART AND VESSELS (2010)
Kynurenine is an endothelium-derived relaxing factor produced during inflammation
Yutang Wang et al.
NATURE MEDICINE (2010)
Guidelines for the diagnosis and treatment of pulmonary hypertension
Nazzareno Galie et al.
EUROPEAN HEART JOURNAL (2009)
C-Reactive Protein A New Predictor of Adverse Outcome in Pulmonary Arterial Hypertension
Rozenn Quarck et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Pulmonary hypertension
Gorev Grubu Uyeleri et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2009)
分享论文
